{"id":2660,"date":"2021-09-23T10:43:05","date_gmt":"2021-09-23T10:43:05","guid":{"rendered":"https:\/\/aceoncology.org\/?p=2660"},"modified":"2021-10-25T07:27:34","modified_gmt":"2021-10-25T07:27:34","slug":"genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/","title":{"rendered":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e"},"content":{"rendered":"\n

\u8f6c\u79fb\u6027\u7ed3\u76f4\u80a0\u764c\u4e2d\u7684 RAS\u3001 BRAFV600E<\/sup>\u548cMMR\/MSI\u7b49\u5206\u5b50\u68c0\u6d4b\u662f\u5e2e\u52a9\u6539\u5584\u60a3\u8005\u7ed3\u5c40\u7684\u4e2a\u4f53\u5316\u6cbb\u7597\u9009\u62e9\u7684\u5173\u952e\uff1b\u4e8c\u4ee3\u6d4b\u5e8f\uff08NGS\uff09\u7b49\u6280\u672f\u7684\u53d1\u5c55\u8868\u660eCRC\u662f\u4e00\u79cd\u9ad8\u5ea6\u5f02\u8d28\u6027\u7684\u75be\u75c5\u3002\u6b64\u5916\uff0c\u5df2\u8bc1\u5b9e\u80bf\u7624\u5185\u6f14\u53d8\u7684\u5206\u5b50\u5f02\u8d28\u6027\uff08\u65f6\u95f4\u5f02\u8d28\u6027\uff09\u53ef\u5f15\u8d77\u6cbb\u7597\u8010\u836f\u3002\u5c3d\u7ba1\u7ec4\u7ec7\u6d3b\u68c0\u662f\u5206\u5b50\u68c0\u6d4b\u7684\u6807\u51c6\u6cbb\u7597\uff0c\u4f46\u8840\u6d46\u6837\u672cctDNA\u6d4b\u5e8f\uff08\u6db2\u4f53\u6d3b\u68c0\uff09\u662f\u4e00\u79cd\u975e\u4fb5\u5165\u6027\u66ff\u4ee3\u65b9\u6cd5\uff0c\u5176\u5728CRC\u7ba1\u7406\u8fc7\u7a0b\u4e2d\u7684\u5e94\u7528\u8d8a\u6765\u8d8a\u591a\u3002\u4f17\u6240\u5468\u77e5\uff0cctDNA\u53ef\u4ee5\u8ffd\u8e2amCRC\u4e2d\u7684RAS\u514b\u9686\uff0c\u5e76\u53ef\u80fd\u901a\u8fc7\u6297EGFR\u518d\u6311\u6218\u6307\u5bfc\u6cbb\u7597\u9009\u62e9\u3002\u7136\u800c\uff0cctDNA\u5982\u4f55\u5728\u5168\u8eab\u6cbb\u7597\u8fc7\u7a0b\u4e2d\u6355\u83b7\u4f53\u7ec6\u80de\u7a81\u53d8\u7684\u8fdb\u5316\uff0c\u4ee5\u53ca\u8fd9\u79cd\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u5bf9\u60a3\u8005\u9884\u540e\u7684\u5f71\u54cd\uff0c\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u662f\u672a\u77e5\u7684\u3002<\/p>\n\n\n\n

\u6765\u81ea\u4e2d\u5c71\u5927\u5b66\u80bf\u7624\u9632\u6cbb\u4e2d\u5fc3\u7684\u7814\u7a76\u56e2\u961f\u5c1d\u8bd5\u5728171\u4f8b\u63a5\u53d7\u4e00\u7ebf\u6cbb\u7597\u7684\u4e0d\u53ef\u5207\u9664mCRC\u60a3\u8005\u7684\u524d\u77bb\u6027\u961f\u5217<\/a>\u4e2d\u7814\u7a76\u8fd9\u4e9b\u95ee\u9898\u3002\u572874\u4f8b\uff0843.3%\uff09\u60a3\u8005\u7684ctDNA\u4e2d\u68c0\u6d4b\u5230\u57fa\u7ebfRAS\u7a81\u53d8\uff0c\u572811\u4f8b\uff086.4%\uff09\u60a3\u8005\u4e2d\u68c0\u6d4b\u51faBRAF\u7a81\u53d8\u3002\u572863\u4f8b\u60a3\u8005\u7684\u914d\u5bf9\u57fa\u7ebf\u7ec4\u7ec7\u548c\u8840\u6d46\u6837\u672c\u4e2d\uff0cctDNA\u548c\u7ec4\u7ec7\u4e4b\u95f4RAS\/BRAFV600E<\/sup>\u72b6\u6001\u7684\u603b\u4f53\u4e00\u81f4\u6027\u4e3a81%\uff0cRAS\u72b6\u6001\u7684\u4e0d\u4e00\u81f4\u7387\u4e3a17.5%\uff0cBRAF\u72b6\u6001\u7684\u4e0d\u4e00\u81f4\u7387\u4e3a1.5%\u3002\u6709\u8da3\u7684\u662f\uff0c\u4e0d\u540c\u8f6c\u79fb\u90e8\u4f4d\u4e4b\u95f4\u7684\u4e00\u81f4\u7387\u4e0d\u540c\uff08\u4ec5\u53d1\u751f\u809d\u8f6c\u79fb\u7684\u60a3\u8005\u4e3a90%\uff0c\u809d\u5916\u8f6c\u79fb\u7684\u60a3\u8005\u4e3a79.1%\uff09\u3002\u5728\u75be\u75c5\u8fdb\u5c55\uff08PD\uff09\u524d\u7684145\u4f8b\u60a3\u8005\u961f\u5217\u4e2d\u8fde\u7eed\u91c7\u96c6\u8840\u6d46\u6837\u672c\uff0c\u4ee5\u8bc4\u4f30\u4e00\u7ebf\u6cbb\u7597\u4e0b\u7684\u57fa\u56e0\u7ec4\u6f14\u53d8\u3002\u4e00\u7ebf\u6cbb\u7597\u4e00\u6bb5\u65f6\u95f4\u540e\uff08\u4e2d\u4f4d4.7\u4e2a\u6708\uff09\uff0c\u5927\u591a\u6570\u57fa\u56e0\u7684\u7a81\u53d8\u9891\u7387\u4e0b\u964d\uff0c\u5728RAS\u548cBRAF\u7a81\u53d8\u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u7684\u53d8\u5316\u6700\u663e\u8457\u3002\u572842.6%\u7684RAS\u7a81\u53d8\u60a3\u8005\u4e2d\u53d1\u73b0\u4e86RAS\u7a81\u53d8\u6e05\u9664\uff0c\u572850%\u7684BRAF\u7a81\u53d8\u60a3\u8005\u4e2d\u53d1\u73b0\u4e86BRAF\u7a81\u53d8\u6e05\u9664\uff0c\u800c\u5206\u522b\u67093.6%\u548c0.7%\u7684\u60a3\u8005\u83b7\u5f97\u4e86\u65b0\u7684RAS\u548cBRAF\u7a81\u53d8\u3002<\/p>\n\n\n\n

\u91cd\u8981\u7684\u662f\uff0c\u8fd9\u4e9bRAS\u548cBRAF\u7684\u57fa\u56e0\u7ec4\u53d8\u5316\u4e0e\u60a3\u8005\u7ed3\u5c40\u76f8\u5173\u3002RAS\u6216BRAF\u6e05\u9664\u60a3\u8005\u7684\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08mPFS\uff09\uff08\u5206\u522b\u4e3a12.8\u4e2a\u6708\u548c\u672a\u8fbe\u5230 [NR]\uff09\u4e0eRAS\u6216BRAF\u6301\u7eed\u91ce\u751f\u578b\u60a3\u8005\u7684mPFS\u76f8\u4f3c\uff08\u5206\u522b\u4e3a13.2\u548c11.5\u4e2a\u6708\uff09\uff0c\u663e\u8457\u4f18\u4e8eRAS\u6216BRAF\u4fdd\u6301\u7a81\u53d8\u7684\u60a3\u8005\uff08\u5206\u522b\u4e3a7.9\u4e2a\u6708\u548c6.4\u4e2a\u6708\uff09\u3002\u540c\u6837\uff0cRAS\u6216BRAF\u6e05\u9664\u60a3\u8005\u7684\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\uff08mOS\uff09\u4e0eRAS\u548cBRAF\u91ce\u751f\u578b\u60a3\u8005\u76f8\u4f3c\uff08NR vs. 31.4\u4e2a\u6708\u548c26.7\u4e2a\u6708\uff09\uff0c\u4f46RAS\u6216BRAF\u4fdd\u6301\u7a81\u53d8\u7684\u60a3\u8005mOS\u663e\u8457\u7f29\u77ed\uff0814.5\u4e2a\u6708\u548c11.4\u4e2a\u6708\uff09\u3002\u65b0\u53d1\u751fRAS\u6216BRAF\u7a81\u53d8\u7684\u60a3\u8005\u4e0eRAS\u6216BRAF\u4fdd\u6301\u7a81\u53d8\u7684\u60a3\u8005\u9884\u540e\u76f8\u4f3c\uff0cPFS\u548cOS\u77ed\u4e8e\u6301\u7eed\u91ce\u751f\u578b\u7684\u60a3\u8005\u3002\u90e8\u5206\u7f13\u89e3\u6216\u75be\u75c5\u7a33\u5b9a\u60a3\u8005\u7684ctDNA\u6c34\u5e73\u4e0b\u964d\uff0c\u75be\u75c5\u8fdb\u5c55\u60a3\u8005\u7684ctDNA\u6c34\u5e73\u5347\u9ad8\u3002\u8fd9\u8868\u660e\u4e86ctDNA\u5728\u7f13\u89e3\u8bc4\u4ef7\u4e2d\u7684\u5e94\u7528\u4ef7\u503c\u3002\u6b64\u5916\uff0c\u7814\u7a76\u8005\u89c2\u5bdf\u5230\u4e00\u7ebf\u6cbb\u7597\u5931\u8d25\u65f6\u4f53\u7ec6\u80de\u7a81\u53d8\u7684\u663e\u8457\u53d8\u5316\u3002\u8fd9\u4e9b\u4fe1\u606f\u53ef\u80fd\u6709\u52a9\u4e8e\u5236\u5b9a\u540e\u7eed\u7684\u6cbb\u7597\u51b3\u7b56\u3002<\/p>\n\n\n\n

\u7814\u7a76\u7ed3\u8bba\u4e2d\uff0c\u4f5c\u8005\u5f3a\u8c03\uff0c\u8fd9\u9879\u524d\u77bb\u6027\u7814\u7a76\u4e3a\u4f7f\u7528ctDNA\u6d4b\u5e8f\u6765\u6355\u83b7mCRC\u7684\u5f02\u8d28\u6027\u548c\u80bf\u7624\u57fa\u56e0\u6f14\u53d8\u63d0\u4f9b\u4e86\u8fdb\u4e00\u6b65\u7684\u8bc1\u636e\u652f\u6301\u3002\u8fd9\u5177\u6709\u4e34\u5e8a\u610f\u4e49\uff0c\u56e0\u4e3a\u8840\u6d46RAS\u548cBRAF\u7a81\u53d8\u72b6\u6001\u7684\u53d8\u5316\u53ef\u9884\u6d4b\u60a3\u8005\u7684\u751f\u5b58\u671f\u3002<\/p>\n\n\n\n

\u53c2\u8003\u6587\u732e<\/strong>:
Wang F, et al. Gut.<\/em> 2021; Sep 6 [Online ahead of print].<\/p>\n","protected":false},"excerpt":{"rendered":"

\u8f6c\u79fb\u6027\u7ed3\u76f4\u80a0\u764c\u4e2d\u7684 RAS\u3001 BRAFV600E\u548cMMR\/MSI\u7b49\u5206\u5b50\u68c0\u6d4b\u662f\u5e2e\u52a9\u6539\u5584\u60a3\u8005\u7ed3\u5c40\u7684\u4e2a\u4f53\u5316\u6cbb\u7597\u9009\u62e9\u7684 […]<\/p>\n","protected":false},"author":3,"featured_media":2652,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2660","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2"],"acf":[],"yoast_head":"\n\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology<\/title>\n<meta name=\"description\" content=\"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-23T10:43:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-25T07:27:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"682\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e\",\"datePublished\":\"2021-09-23T10:43:05+00:00\",\"dateModified\":\"2021-10-25T07:27:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\"},\"wordCount\":79,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg\",\"articleSection\":[\"\u6587\u7ae0\u7cbe\u8981\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\",\"name\":\"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg\",\"datePublished\":\"2021-09-23T10:43:05+00:00\",\"dateModified\":\"2021-10-25T07:27:34+00:00\",\"description\":\"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg\",\"width\":1024,\"height\":682},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology","description":"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/","og_locale":"zh_CN","og_type":"article","og_title":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology","og_description":"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40","og_url":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/","og_site_name":"ACE Oncology","article_published_time":"2021-09-23T10:43:05+00:00","article_modified_time":"2021-10-25T07:27:34+00:00","og_image":[{"width":1024,"height":682,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg","type":"image\/jpeg"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e","datePublished":"2021-09-23T10:43:05+00:00","dateModified":"2021-10-25T07:27:34+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/"},"wordCount":79,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg","articleSection":["\u6587\u7ae0\u7cbe\u8981"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/","url":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/","name":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg","datePublished":"2021-09-23T10:43:05+00:00","dateModified":"2021-10-25T07:27:34+00:00","description":"mCRC\u6cbb\u7597\u8fc7\u7a0b\u4e2dctDNA\u7684\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u53ef\u80fd\u5f71\u54cd\u60a3\u8005\u7ed3\u5c40","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/09\/Picture-Blog-Post-59_Circulating-Tumor-DNA.jpg","width":1024,"height":682},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/genomic-heterogeneity-in-circulating-tumor-dna-during-therapy-and-mcrc-prognosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u6cbb\u7597\u671f\u95f4ctDNA\u57fa\u56e0\u7ec4\u5f02\u8d28\u6027\u6216\u5f71\u54cdmCRC\u9884\u540e"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=2660"}],"version-history":[{"count":6,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2660\/revisions"}],"predecessor-version":[{"id":2835,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2660\/revisions\/2835"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/2652"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=2660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=2660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=2660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}